GlassScriptPhysician profile
Jaime Calderon
NPI 1295025799
$2,524.42
in general payments reported to CMS, 2019-2025
9 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what 84% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.13 · 2022: $489 · 2023: $417 · 2024: $308 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $938.60 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $782.97 | 2021-2025 | Xifaxan, Trulance |
| Ardelyx, INC. | $242.74 | 2022-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $151.57 | 2025 | Rezdiffra |
| Revance Therapeutics, INC. | $148.18 | 2025 | Daxxify |
| Lilly USA, LLC | $134.97 | 2025 | Zepbound, Omvoh |
| Ironwood Pharmaceuticals, INC | $62.55 | 2024 | |
| Qol Medical, LLC | $40.29 | 2024 | Sucraid |
| Daiichi Sankyo INC. | $22.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Calderon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.